GCG and prostate cancer: Hyperinsulinemia is associated with the increased risk of breast cancer (31), endometrial cancer (32), ovarian cancer (33) and prostate cancer (34), and is closely related to the increased mortality of pancreatic cancer and breast cancer (35, 36), and some studies indicate that glucagon increases the overall mortality of cancer (37).